A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

NCT00717769 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: SUN13834
DRUG: Placebo

Sponsor

Daiichi Sankyo